Continuum Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $774K | Buy |
1,739
+74
| +4% | +$32.9K | 0.09% | 202 |
|
|
2025
Q1 | $807K | Buy |
1,665
+89
| +6% | +$43.1K | 0.1% | 171 |
|
|
2024
Q4 | $635K | Buy |
1,576
+11
| +0.7% | +$4.43K | 0.08% | 213 |
|
|
2024
Q3 | $757K | Sell |
1,565
-116
| -7% | -$56.1K | 0.1% | 193 |
|
|
2024
Q2 | $788K | Buy |
1,681
+71
| +4% | +$33.3K | 0.11% | 179 |
|
|
2024
Q1 | $675K | Buy |
1,610
+269
| +20% | +$113K | 0.1% | 197 |
|
|
2023
Q4 | $547K | Buy |
1,341
+81
| +6% | +$33K | 0.08% | 267 |
|
|
2023
Q3 | $438K | Buy |
1,260
+95
| +8% | +$33K | 0.07% | 297 |
|
|
2023
Q2 | $410K | Sell |
1,165
-42
| -3% | -$14.8K | 0.07% | 317 |
|
|
2023
Q1 | $380K | Buy |
1,207
+425
| +54% | +$134K | 0.06% | 305 |
|
|
2022
Q4 | $226K | Sell |
782
-26
| -3% | -$7.51K | 0.04% | 385 |
|
|
2022
Q3 | $234K | Buy |
+808
| New | +$234K | 0.04% | 358 |
|